There’s a new Alzheimer’s drug, so what’s the problem? A Johns Hopkins doctor explains.
Baltimore Sun -

A new Alzheimer's drug was approved by the FDA, but an advisory panel has questioned whether it works.

Read this story at

Loading...

Related Articles